Kim Sung Han, Kwon Whi-An, Joung Jae Young, Seo Ho Kyung, Lee Kang Hyun, Chung Jinsoo
Department of Urology, Center for Prostate Cancer, National Cancer Center, Goyang 410-769, South Korea.
World J Nephrol. 2018 Dec 17;7(8):155-160. doi: 10.5527/wjn.v7.i8.155.
Clear cell papillary renal cell carcinoma (ccpRCC) was recently established as a distinct type of epithelial neoplasm by the International Society of Urological Pathology Vancouver Classification of Renal Neoplasia. Here, we report a case of partial nephrectomy for a ccpRCC detected during the routine follow-up of a previously treated liposarcoma in a 70-year-old male patient. The patient was referred to the urology department for a right-sided renal mass (size: 2 cm) detected during routine annual imaging follow-up for a malignant right inguinal fibrous histocytoma and liposarcoma that had been diagnosed 6 and 4 years earlier, respectively, and treated with surgery and adjuvant radiation therapy. Following partial nephrectomy, the renal mass was pathologically diagnosed as ccpRCC, and immunohistochemistry revealed carbonic anhydrase 9 (CA9) expression. No recurrences or metastases were detected on follow-up imaging for 6 months. This is the first report of partial nephrectomy for incidentally discovered CA9-positive ccpRCC.
透明细胞乳头状肾细胞癌(ccpRCC)最近被国际泌尿病理学会温哥华肾肿瘤分类确认为一种独特的上皮性肿瘤类型。在此,我们报告一例70岁男性患者,其先前治疗的脂肪肉瘤在常规随访期间检测出ccpRCC并行部分肾切除术。该患者因在常规年度影像学随访中发现右侧肾脏肿块(大小:2 cm)而被转诊至泌尿外科,该患者分别于6年前和4年前被诊断为右侧腹股沟恶性纤维组织细胞瘤和脂肪肉瘤,并接受了手术及辅助放疗。部分肾切除术后,肾脏肿块经病理诊断为ccpRCC,免疫组化显示碳酸酐酶9(CA9)表达。随访6个月的影像学检查未发现复发或转移。这是关于偶然发现的CA9阳性ccpRCC行部分肾切除术的首例报告。